Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Expression of p27and p18in human multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors

Autor: Conemans, E B, Raicu-Ionita, G M, Pieterman, C R C, Dreijerink, K M A, Dekkers, O M, Hermus, A R, de Herder, W W, Drent, M L, van der Horst-Schrivers, A N A, Havekes, B, Bisschop, P H, Offerhaus, G J, Borel Rinkes, I H M, Valk, G D, Timmers, H Th M, Vriens, M R

Publikováno v: Conemans, E B, Raicu-Ionita, G M, Pieterman, C R C, Dreijerink, K M A, Dekkers, O M, Hermus, A R, de Herder, W W, Drent, M L, van der Horst-Schrivers, A N A, Havekes, B, Bisschop, P H, Offerhaus, G J, Borel Rinkes, I H M, Valk, G D, Timmers, H T M & Vriens, M R 2018, ' Expression of p27and p18in human multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors ', Journal of Endocrinological Investigation, vol. 41, no. 6, pp. 655-661 . https://doi.org/10.1007/s40618-017-0783-y
Journal of Endocrinological Investigation, 41(6), 655-661. Editrice Kurtis s.r.l.

PURPOSE: Pancreatic neuroendocrine tumors are a major manifestation of multiple endocrine neoplasia type 1 (MEN1). This tumor syndrome is caused by germline mutations in MEN1, encoding menin. Insight into pathogenesis of these tumors might lead to ne

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d22352a52ede634a8a36a85cb4bbf20a
https://hdl.handle.net/1871.1/5c08edb1-b7e4-424a-bc3f-5a0c89c2a1ed

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Increased prevalence of impaired fasting glucose in MEN1 gene mutation carriers

Autor: Van Wijk, Jeroen P H, Dreijerink, K. M A, Pieterman, C. R C, Lips, C. J M, Zelissen, P. M J, Valk, G. D.

Publikováno v: Van Wijk, J P H, Dreijerink, K M A, Pieterman, C R C, Lips, C J M, Zelissen, P M J & Valk, G D 2012, ' Increased prevalence of impaired fasting glucose in MEN1 gene mutation carriers ', Clinical Endocrinology, vol. 76, no. 1, pp. 67-71 . https://doi.org/10.1111/j.1365-2265.2011.04166.x
Clinical Endocrinology, 76(1), 67-71. Wiley-Blackwell

Objective Multiple endocrine neoplasia type 1 (MEN1) is a hereditary syndrome characterized by parathyroid, gastroenteropancreatic, pituitary and adrenal tumours. Cardiovascular disease has been identified as an important cause of death in MEN1 patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::35c2b98b5e3ae774a6e9d55f1922b68b
https://research.vumc.nl/en/publications/1aa33f36-e758-4e0e-999c-419394152d7c